Showing results (191-200 of 211) with videos related to

Sort By:
Pageof 22
Journal of Virology|March 15, 2019
Modulation of the CCR5 Receptor/Ligand Axis by Seminal Plasma and the Utility of In Vitro versus In Vivo ModelsJennifer A Juno, Kathleen M Wragg, Anne B Kristensen, et al.
Immunology and Cell Biology|September 6, 2023
Mucosal antibody responses following Vaxzevria vaccinationKevin J Selva, Pradhipa Ramanathan, Ebene R Haycroft, et al.
Scientific Reports|May 26, 2017
The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasitesL Dembele, X Ang, M Chavchich, et al.
Ebiomedicine|December 21, 2025
Elevated SARS-CoV-2 IgG4 in plasma and mucosa following repeated mRNA boosters impact antibody functions to Omicron and sarbecovirusesKevin J Selva, Wen Shi Lee, Alther L Enriquez, et al.
JCI Insight|September 22, 2023
Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infectionsKevin J Selva, Pradhipa Ramanathan, Ebene R Haycroft, et al.
Nature Communications|September 29, 2021
Probabilistic tsunami forecasting for early warningJ Selva, S Lorito, M Volpe, et al.
The Journal of Clinical Investigation|July 11, 2024
Randomized controlled trial reveals no benefit to a 3-month delay in COVID-19 mRNA booster vaccineWen Shi Lee, Jennifer Audsley, Mai-Chi Trieu, et al.
JCI Insight|January 9, 2025
Randomized trial of same- versus opposite-arm coadministration of inactivated influenza and SARS-CoV-2 mRNA vaccinesWen Shi Lee, Kevin J Selva, Jennifer Audsley, et al.
ACS Nano|June 27, 2022
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA VaccineYi Ju, Wen Shi Lee, Emily H Pilkington, et al.
JCI Insight|July 12, 2021
Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assayEster Lopez, Ebene R Haycroft, Amy Adair, et al.
Pageof 22